MMV, Africa CDC sign MoU to support African manufacturers of malaria medicine Medicines for Malaria Venture (MMV) and the Africa Centre for Disease Control and Prevention (Africa CDC), have signed a Memorandum of Understanding (MoU), focused on strengthening African manufacturing of malaria medicines on the margins of the 2nd International Conference on Public Health in Africa (CPHIA 2022), taking place in Kigali, Rwanda. The objective of the MoU is to jointly enhance supply security and facilitate equitable access to approved antimalarials thereby maximising the use and health impact of existing products...